Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248984 · ClinicalTrials.gov registry record · Phase 4
Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING)
A Phase 4 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
NCT05248984 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 92 participants.
The verdict
NCT05248984, a Phase 4 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
Study Summary
This is a randomized controlled single blinded trial to compare the morphine milligram equivalents (MME) use in the first 24 hours postoperatively after cesarean section in patients receiving a single dose of 30 mg intravenous ketorolac vs. 60 mg intravenous ketorolac in the operating room after the end of surgery.
Interventions
- DRUG Ketorolac 30 Mg
- DRUG Ketorolac 60 Mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2023-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05248984
The ClinicalTrials.gov registry entry for NCT05248984 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac 30 Mg is the first listed.
NCT05248984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05248984 about?
NCT05248984 is a clinical study titled "Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING)". This is a randomized controlled single blinded trial to compare the morphine milligram equivalents (MME) use in the first 24 hours postoperatively after cesarean section in patients receiving a single dose of 30 mg intravenous ketorolac vs. 60 mg intravenous ketorolac in the operating room after the...
What is the current status of trial NCT05248984?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2022-06-08. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT05248984?
The interventions under investigation include: Ketorolac 30 Mg (DRUG), Ketorolac 60 Mg (DRUG).
Who is sponsoring clinical trial NCT05248984?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.